Yes Bank: Steady improvement, but two contradictions chip away at trust
Q1 profit got a one-time lift; management held SR recovery guidance despite a weak start and reversed stance on gold loans.
The numbers
- Net profit ₹1,071 cr, up 34% y/y, but ₹728 cr came from a one-time reserve transfer.
- Gross NPA fell to 1.3% from 1.6% a year ago; net NPA remained at 0.2%.
- Core NII grew 13%, operating profit expanded 25% as provisions eased.
- SR recovery gains in Q1 were just ₹86 cr, a fraction of the ₹555 cr in Q3 FY26.
Management's story
- Reaffirmed SR recovery guidance of ₹800-1,000 cr for FY27, though execution depends on JC Flowers and Q1 run-rate is weak.
- Targets NIM above 3% by FY28 through RIDF rundown, deposit repricing, and CASA mix.
- Plans to build gold loan capabilities after deliberately deprioritizing them six months ago, without citing a market trigger.
- Expects advances growth of 15-17% for FY27; retail disbursements rose 27.5% y/y.
“We maintain our guidance of 800-1,000 crores of gains from this portfolio for this FY27... It is possible that we could get higher than 800-1,000 crores or it is also possible that we could be slightly lower.”
— Yes Bank management, July 2026 call
Where they diverge
The most glaring split is between management's unchanged SR recovery guidance and the actual Q1 haul of ₹86 cr against a ₹555 cr quarterly run-rate earlier. The bank admits JC Flowers controls timing but refuses to tighten the band, weakening the credibility of any forward-looking target. The gold loan pivot, unexplained and abrupt, adds to the perception of strategy drift.
The full read
Yes Bank's Q1 earnings look steady, but two contradictions in management's narrative erode the trust the bank has rebuilt. The headline 34% profit jump to ₹1,071 cr was flattered by a ₹728 cr reserve transfer. Core operating profit grew 25% and asset quality improved to a 1.3% gross NPA, but that is not the story. The call revealed a guidance credibility problem: management maintained its FY27 SR recovery target of ₹800-1,000 cr even though Q1 delivered just ₹86 cr, a sharp drop from ₹555 cr in Q3 FY26. The bank admits it cannot control JC Flowers' execution pace but will not revise the range. Then there is the gold loan pivot, six months after deliberately deprioritizing the product, management says it may start building capabilities, with no explanation. Meanwhile, NIM held at 2.7%, and the path to 3% remains contingent on structural levers. Rating upgrades from S&P, ICRA, and CARE validate the progress, but consistency in guidance is the currency of trust. This quarter lost some.
What we're watching
- SR recovery trajectory in Q2: any acceleration needed to hit even the low end of ₹800 cr.
- Gold loan disbursement growth in coming quarters to see if capability-building translates into action.
- NIM movement: if it remains at 2.7% for another quarter, the 3% target slips further.
- Capital raise timing: optionality is fine, but markets will note if the bank taps the up to ₹16,000 cr.